Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2.
暂无分享,去创建一个
R. Sartor | R. Langenbach | S. Morham | O. Smithies | L. Dieleman | O Smithies | R Langenbach | O Morteau | S G Morham | R Sellon | L A Dieleman | R B Sartor | R. Sellon | O. Morteau | Oliver Smithies | O. Morteau | Rance K. Sellon | Robert Langenbach
[1] S. Boyce,et al. Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745,337: a novel nonsteroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach. , 1995, The Journal of pharmacology and experimental therapeutics.
[2] T G Cotter,et al. Heat shock proteins increase resistance to apoptosis. , 1996, Experimental cell research.
[3] R. Sartor,et al. Resident Enteric Bacteria Are Necessary for Development of Spontaneous Colitis and Immune System Activation in Interleukin-10-Deficient Mice , 1998, Infection and Immunity.
[4] R. Langenbach,et al. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse , 1995, Cell.
[5] J. Larrick,et al. Tumor necrosis factor stimulates interleukin-1 and prostaglandin E2 production in resting macrophages. , 1986, Biochemical and biophysical research communications.
[6] H. Cooper,et al. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. , 1993, Laboratory investigation; a journal of technical methods and pathology.
[7] Han,et al. Specific NF‐κB blockade selectively inhibits tumour necrosis factor‐α‐induced COX‐2 but not constitutive COX‐1 gene expression in HT‐29 cells , 1998, Immunology.
[8] K. Seibert,et al. Cyclooxygenase-2 inhibitors: a new class of anti-inflammatory agents that spare the gastrointestinal tract. , 1996, Gastroenterology clinics of North America.
[9] M. Kasuga,et al. Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. , 1997, Gastroenterology.
[10] W. Dröge,et al. Tumor necrosis factor-induced activation of peritoneal macrophages is regulated by prostaglandin E2 and cAMP. , 1988, Journal of immunology.
[11] Julia W. Chang,et al. Interleukin‐1β Induces Prostaglandin G/H Synthase‐2 (Cyclooxygenase‐2) in Primary Murine Astrocyte Cultures , 1996, Journal of neurochemistry.
[12] K. Seibert,et al. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[13] B. Evers,et al. Inhibition of heat-shock protein 70 induction in intestinal cells overexpressing cyclooxygenase 2. , 1998, Gastroenterology.
[14] J. Wallace,et al. Exacerbation of experimental colitis by nonsteroidal anti-inflammatory drugs is not related to elevated leukotriene B4 synthesis. , 1992, Gastroenterology.
[15] P. Moore,et al. SULPHASALAZINE IS A POTENT INHIBITOR OF PROSTAGLANDIN 15‐HYDROXYDEHYDROGENASE: POSSIBLE BASIS FOR THERAPEUTIC ACTION IN ULCERATIVE COLITIS , 1978, British journal of pharmacology.
[16] V. Winn,et al. A serum- and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein. , 1991, The Journal of biological chemistry.
[17] Hyung-Suk Kim,et al. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration , 1995, Cell.
[18] C. Ling,et al. Apoptosis in heat-induced cell killing: the protective role of hsp-70 and the sensitization effect of the c-myc gene. , 1996, Radiation research.
[19] K. Deschryver,et al. Treatment with 16,16'-dimethyl prostaglandin E2 before and after induction of colitis with trinitrobenzenesulfonic acid in rats decreases inflammation. , 1989, Gastroenterology.
[20] T. Strom,et al. Prostaglandins posttranscriptionally inhibit monocyte expression of interleukin 1 activity by increasing intracellular cyclic adenosine monophosphate. , 1986, Journal of immunology.
[21] C. Leffler,et al. Gastroduodenal ulceration in rabbits producing antibodies to prostaglandins. , 1985, Prostaglandins.
[22] U. Zor,et al. Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine. , 1978, Gastroenterology.
[23] J. Wallace,et al. Cyclooxygenase 1 contributes to inflammatory responses in rats and mice: implications for gastrointestinal toxicity. , 1998, Gastroenterology.
[24] A. Bylund-Fellenius,et al. Experimental colitis induced by dextran sulphate sodium in mice: beneficial effects of sulphasalazine and olsalazine , 1998, Alimentary pharmacology & therapeutics.
[25] A. Macpherson,et al. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. , 1993, Gastroenterology.
[26] E. Bloemena,et al. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines , 1998, Clinical and experimental immunology.
[27] J. Marcinkiewicz,et al. In vitro cytokine release by activated murine peritoneal macrophages: role of prostaglandins in the differential regulation of tumor necrosis factor alpha, interleukin 1, and interleukin 6. , 1991, Cytokine.
[28] C. MacArthur,et al. Misoprostol provides a colonic mucosal protective effect during acetic acid-induced colitis in rats. , 1990, Gastroenterology.
[29] J. Wallace,et al. Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2. , 1996, The Journal of clinical investigation.
[30] S. Cohn,et al. Prostaglandins prevent decreased epithelial cell proliferation associated with dextran sodium sulfate injury in mice. , 1998, Gastroenterology.
[31] M. Fishman,et al. Impaired Defense of Intestinal Mucosa in Mice Lacking Intestinal Trefoil Factor , 1996, Science.
[32] S. Kunkel,et al. Prostaglandins as endogenous mediators of interleukin 1 production. , 1986, Journal of immunology.
[33] N. Yeomans,et al. Selective COX-2 inhibitors: are they safe for the stomach? , 1998, Gastroenterology.
[34] W. Xie,et al. Mitogen‐inducible prostaglandin G/H synthase: A new target for nonsteroidal antiinflammatory drugs , 1992 .
[35] O. Morteau. COX-2: promoting tolerance , 1999, Nature Medicine.
[36] K. Seibert,et al. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[37] L. Schwartz,et al. Inflammatory mediators of experimental colitis in rats. , 1989, Gastroenterology.
[38] K. Seibert,et al. Crypt stem cell survival in the mouse intestinal epithelium is regulated by prostaglandins synthesized through cyclooxygenase-1. , 1997, The Journal of clinical investigation.
[39] W. Stenson. Cyclooxygenase 2 and wound healing in the stomach. , 1997, Gastroenterology.
[40] H. Kaufmann,et al. Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease. , 1987, Annals of internal medicine.
[41] R. DuBois,et al. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2 , 1995, Cell.
[42] D. Gilroy,et al. Inducible cyclooxygenase may have anti-inflammatory properties , 1999, Nature Medicine.
[43] J. Wallace,et al. Induction of cyclooxygenase 1 and 2 in the rat stomach during endotoxemia: role in resistance to damage. , 1997, Gastroenterology.
[44] S. Laulederkind,et al. Compensatory Prostaglandin E2 Biosynthesis in Cyclooxygenase 1 or 2 Null Cells , 1998, The Journal of experimental medicine.
[45] R. Lorenz,et al. Cyclooxygenase-2-dependent arachidonic acid metabolites are essential modulators of the intestinal immune response to dietary antigen , 1999, Nature Medicine.
[46] J. Redfern,et al. Gastrointestinal ulcer formation in rabbits immunized with prostaglandin E2. , 1987, Gastroenterology.